What are the latest clinical trials for Sarcoma in 2026

Latest Clinical Trials for Sarcoma in 2026

I appreciate your question about current clinical trials. However, I need to be transparent about an important limitation: my knowledge was last updated in April 2025, so I don't have access to trials that may have been newly launched or updated specifically in 2026.

That said, I can share what the most current guidelines tell us about the direction of sarcoma research and treatment development, based on the latest NCCN Guidelines (Version 1.2025).

Current Treatment Directions & Active Research Areas

According to the NCCN Guidelines for Soft Tissue Sarcoma (2025), several therapeutic approaches are actively being studied:

Emerging Systemic Therapy Options

The latest guidelines highlight several agents with growing evidence:

• Trabectedin - Recently moved to "Preferred" status for certain sarcoma types (particularly leiomyosarcoma with doxorubicin)
• Eribulin, Dacarbazine, and Gemcitabine-based combinations - Recommended as category 2A options
• Immunotherapy approaches - Nivolumab and atezolizumab are being evaluated, with new subcutaneous formulations (nivolumab and hyaluronidase-nvhy; atezolizumab and hyaluronidase-tqjs) now available
• Targeted therapies - Including trametinib for specific sarcoma subtypes

Radiation Therapy Innovation

Research continues on intraoperative radiation therapy (IORT) for retroperitoneal sarcomas, with ongoing phase I/II studies (NCT01566123) examining neoadjuvant radiation followed by surgery with IORT showing promising results.

Interventional Oncology

For patients with liver metastases, transarterial chemoembolization (TACE) has shown improved overall survival in surgically unresectable disease.

How to Find Current 2026 Trials

To find the most up-to-date clinical trials launching in 2026, I recommend:

1. ClinicalTrials.gov (www.clinicaltrials.gov)

   • Search: "sarcoma" + your specific sarcoma type
   • Filter by: Status "Recruiting" or "Not yet recruiting"
   • Filter by: Location (your country/region)

2. NCCN Member Institutions

   • Many leading cancer centers have dedicated sarcoma programs with active trials
   • Ask your oncologist which trials they're enrolling patients in

3. Sarcoma-Specific Resources

   • Sarcoma Alliance (sarcomaalliance.org) - maintains trial listings
   • National Institutes of Health (NIH) - NCI cancer trial information

4. Your Oncology Team

   • Your sarcoma specialist will know about trials appropriate for YOUR specific diagnosis, stage, and histology

Questions to Ask Your Oncologist About Trials

If you're interested in clinical trial participation:

1. "Are there any active clinical trials at your institution that match my sarcoma type and stage?"
2. "What are the inclusion/exclusion criteria, and do I qualify?"
3. "What would participation involve in terms of visits, tests, and time commitment?"
4. "What are the potential benefits and risks compared to standard treatment?"
5. "How would trial participation affect my standard treatment plan?"

Important Context

According to NCCN Guidelines, the choice of treatment—whether standard therapy or clinical trial participation—depends on several factors specific to YOUR case:

• Your sarcoma subtype and grade
• Tumor size and location
• Whether disease is localized or metastatic
• Your overall health and functional status
• Your preferences and goals of care

Your oncologist will help determine which approach is most appropriate for your individual situation.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions about clinical trial participation.